Subscribe
handing-over-100-dollar-bills
21 March 2018Americas

J&J plans to sell LifeScan for $2.1bn

Johnson & Johnson (J&J) has revealed plans to sell LifeScan, its blood glucose monitoring unit, for $2.1 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.


Editor's picks

Why US patent reform is ‘essential’ for US economic prosperity and security
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

Editor's picks

Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

More on this story

Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.

More on this story

Europe
J&J to acquire maker of 3D-printed spinal implants
14 September 2018   Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
Big Pharma
J&J to boost medical device division with acquisition
22 February 2018   Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.

More features

UPC orders 17-country ban on EOFlow's pumps in Insulet feud
US warns of rising counterfeit drug threat from India and China
Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit
Biotech and healthcare expert returns to Latham & Watkins
AstraZeneca to appeal invalidated diabetes patent in generics dispute
Why US patent reform is ‘essential’ for US economic prosperity and security
Medical company sees $452m trade secrets award cut by 87%
Fed Circ: Generic doesn’t infringe Metacel MS drug